PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- Resource Type
- Article
- Authors
- Raal, Frederick J; Stein, Evan A; Dufour, Robert; Turner, Traci; Civeira, Fernando; Burgess, Lesley; Langslet, Gisle; Scott, Russell; Olsson, Anders G; Sullivan, David; Hovingh, G Kees; Cariou, Bertrand; Gouni-Berthold, Ioanna; Somaratne, Ransi; Bridges, Ian; Scott, Rob; Wasserman, Scott M; Gaudet, Daniel
- Source
- In The Lancet 24-30 January 2015 385(9965):331-340
- Subject
- Primary Research
Articles
- Language
- ISSN
- 0140-6736